Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068797A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
08/21/2003WO2003068794A1 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof
08/21/2003WO2003068793A1 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
08/21/2003WO2003068792A1 Process for producing erythromycin a derivative
08/21/2003WO2003068790A2 Macrolide antibacterial compounds
08/21/2003WO2003068774A1 Tricyclic n-acyl compounds
08/21/2003WO2003068772A1 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy
08/21/2003WO2003068771A1 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068770A1 R- (-) -1- [2- (7-CHLOROBENZO [b] THIOPHEN-3 -YL- METHOXY) -2- (2,4-DICHLOROPHENYL) -ETHYL] -1H-IMIDAZOLE
08/21/2003WO2003068769A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
08/21/2003WO2003068768A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
08/21/2003WO2003068766A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
08/21/2003WO2003068760A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068757A1 Novel pyridin- and pyrimidin-derivatives
08/21/2003WO2003068756A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)]-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
08/21/2003WO2003068755A1 Novel tricycloimidazoline derivatives, method for production and use thereof as medicaments
08/21/2003WO2003068754A1 Therapeutic substituted indazole derivatives
08/21/2003WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003WO2003068751A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders
08/21/2003WO2003068750A1 Jnk inhibitor
08/21/2003WO2003068749A1 Vanilloid receptor modulators
08/21/2003WO2003068748A1 Novel pyridine- and quinoline-derivatives
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068746A1 Aryl ureas as kinase inhibitors
08/21/2003WO2003068744A1 Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068742A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
08/21/2003WO2003068732A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
08/21/2003WO2003068725A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
08/21/2003WO2003068315A1 A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males
08/21/2003WO2003068314A1 Pulmonary administration of 6-alpha-alkylated testosterone derivatives for androgen replacement therapy
08/21/2003WO2003068270A1 Method of radio-labelling biomolecules
08/21/2003WO2003068267A1 Composition for oral or rectal administration
08/21/2003WO2003068266A1 Oral solid solution formulation of a poorly water-soluble active substance
08/21/2003WO2003068265A1 Methods and compositions for treating hyperproliferative conditions
08/21/2003WO2003068264A1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors
08/21/2003WO2003068263A1 Remedy for hypertension
08/21/2003WO2003068261A2 Means and methods for altering the motility of the gastrointestinal tract
08/21/2003WO2003068257A1 Cancer therapy
08/21/2003WO2003068254A1 Glycosaminoglycan-dnase combination therapy
08/21/2003WO2003068253A1 Methods and compositions for the treatment of eye diseases
08/21/2003WO2003068246A2 Improvements in or relating to compositions
08/21/2003WO2003068245A1 Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator
08/21/2003WO2003068244A1 Methods of inhibiting orthopoxvirus replication with nucleoside compounds
08/21/2003WO2003068243A1 Carbohydrate-based anti-wrinkle and tissue remodelling compounds
08/21/2003WO2003068241A1 Percutaneous preparations
08/21/2003WO2003068240A1 Alpha-substituted heteroarylalkyl phosphonate derivattives
08/21/2003WO2003068239A1 Novel drugs for external use
08/21/2003WO2003068238A1 Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
08/21/2003WO2003068237A1 Beta-sheet mimetics and composition and methods relating thereto
08/21/2003WO2003068236A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068235A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068234A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068233A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068232A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068231A2 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068228A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003WO2003068227A1 5-ht2b receptor antagonists
08/21/2003WO2003068226A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
08/21/2003WO2003068225A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
08/21/2003WO2003068224A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
08/21/2003WO2003068223A1 Aryl ureas with raf kinase and angiogenesis inhibiting activity
08/21/2003WO2003068222A1 Methods of reducing rhinovirus contagion and related compositions
08/21/2003WO2003068220A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
08/21/2003WO2003068219A1 Use of anethole dithiolethione in lung cancer chemoprevention
08/21/2003WO2003068218A1 Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
08/21/2003WO2003068217A1 Biphenil derivatives and their use as antiandrogenic agents
08/21/2003WO2003068216A1 The use of omega-3 polyunsaturated acids ethyl esters in patients suffering from heart failure
08/21/2003WO2003068215A1 Drugs for mitochondrial diseases
08/21/2003WO2003068214A1 Novel preventive for infections
08/21/2003WO2003068213A1 Active ingredient for producing a substance containing isocitrate for influencing the coagulation tendency of blood
08/21/2003WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003WO2003068211A1 Methods of treating attention deficit/hyperactivity disorder (adhd)
08/21/2003WO2003068210A1 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
08/21/2003WO2003068209A1 Metformin salts of lipophilic acids
08/21/2003WO2003068208A1 Methods of reducing angiogenesis
08/21/2003WO2003068207A2 Partial dopamine-d2 receptor agonist plus serotonin and/oder noradrenaline inhibitor activity
08/21/2003WO2003068206A1 Pharmaceutical compositions comprising terbutaline or salbutamol in combination with guaiphenesine
08/21/2003WO2003068205A1 Compositions and foods for improving lipid metabolism
08/21/2003WO2003068203A1 Use of a combination of a non-steroidal anti-inflammatory agent and guaifenesin for the treatment of acute pain
08/21/2003WO2003068202A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/21/2003WO2003068200A2 Novel therapeutic application for a composition
08/21/2003WO2003068199A1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
08/21/2003WO2003068196A1 Colonic release composition
08/21/2003WO2003068195A1 Oral dosage form for controlled drug release
08/21/2003WO2003068193A1 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
08/21/2003WO2003068191A1 Formulations of atorvastatin stabilized with alkali metal additions
08/21/2003WO2003068188A1 Combination therapy for respiratory disorders
08/21/2003WO2003068187A1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
08/21/2003WO2003068186A1 Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
08/21/2003WO2003068171A2 Method and composition for treatment of inflammation and aids-associated neurological disorders
08/21/2003WO2003068170A2 Enzyme treatment of foodstuffs for celiac sprue
08/21/2003WO2003068166A2 Treatment of ophthalmic disorders using urea and urea derivatives
08/21/2003WO2003068164A2 Dosing regimen for gemcitabine hcv therapy
08/21/2003WO2003068162A2 Modified fluorinated nucleoside analogues
08/21/2003WO2003068159A2 Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
08/21/2003WO2003068157A2 Kinase inhibitors and methods of use thereof
1 ... 5366 5367 5368 5369 5370 5371 5372 5373 5374 5375 5376 5377 5378 5379 5380 5381 5382 5383 5384 5385 5386 ... 7860